MedTrace Logo

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group

NCT03978039 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150000

Last updated 2025-09-04

No results posted yet for this study

Summary

The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \[RESOS\] / French expert network dedicated to the pathology of sarcomas \[RREPS\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas \[NETSARC\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples.

Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes.

With the financial support of the French National Cancer Institute \[Institut National du cancer \[INCa\]).

Conditions

  • Sarcoma

Interventions

DRUG

Chemotherapy

treatment as per standard of care

DRUG

Immunotherapeutic Agent

treatment as per standard of care

DRUG

target treatment

treatment as per standard of care

PROCEDURE

Surgery

treatment as per standard of care

RADIATION

Radiotherapy

treatment as per standard of care

Sponsors & Collaborators

  • French Sarcoma Group

    collaborator OTHER

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • Maud Toulmonde, MD · Institut Bergonié, Bordeaux, France

  • Axel Le Cesne, MD/PhD · Institut Gustave Roussy, Villejuif, France

  • Jean-Yves Blay, MD/PhD · Centre Léon Bérard, Lyon, France

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2030-12-31
Completion
2035-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03978039 on ClinicalTrials.gov